Insider Holders & Insider Ownership - Horizon Therapeutics Public Ltd Co (HZNP)

List of insiders holdings for Horizon Therapeutics Public Ltd Co:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
# Insider Holder Name Report
Date Time		 Shares Owned
Directly
Indirectly		 Total
Shares Owned		 Filing
1 ESSEX WOODLANDS HEALTH VENTURES FUND VII LP
10% Owner		 2012-03-05 17:35:41 5,755,100
0		 5,755,100 Form 4
2 Johann Peter
Director		 2011-08-04 17:15:36 0
4,590,751		 4,590,751 Form 4
3 VENKATARAMAN BALAJI
Former 10% Owner		 2015-03-04 16:00:59 4,586,317
0		 4,586,317 Form 13D
4 FORMELA JEAN FRANCOIS
Director
10% Owner		 2012-03-06 15:28:38 0
3,895,404		 3,895,404 Form 4
5 Quaker BioVentures II LP
10% Owner		 2014-08-07 09:00:16 3,547,457
0		 3,547,457 Form 13G
6 ATLAS VENTURE FUND VI LP
Atlas Venture Associates VI Inc
ATLAS VENTURE ENTREPRENEURS FUND VI LP
Atlas Venture Fund VI GmbH & Co KG
10% Owner		 2015-02-12 14:13:42 3,386,898
0		 3,386,898 Form 13G
7 ATLAS VENTURE FUND VI LP
Atlas Venture Fund VI GmbH & Co KG
Atlas Venture Associates VI L.P.
ATLAS VENTURE ENTREPRENEURS FUND VI LP
10% Owner		 2015-02-12 14:13:42 3,386,898
0		 3,386,898 Form 13G
8 BOCK LOUIS C
Director		 2011-08-04 17:35:14 0
2,266,631		 2,266,631 Form 4
9 Scale Venture Partners II LP
Scale Venture Management II LLC
MITCHELL KATE
O'Driscoll Rory
Wienbar Sharon L
10% Owner		 2011-08-12 13:19:44 2,266,631
0		 2,266,631 Form 13D
10 NGN BIOMED OPPORTUNITY I GMBH & CO. BETEILIGUNGS KG
NGN BioMed Opportunity I L P
10% Owner		 2011-07-28 17:33:25 2,107,422
0		 2,107,422 Form 3
11 Birner Hubert
Director		 2011-08-04 17:14:32 0
1,672,158		 1,672,158 Form 4
12 Carey Robert
EVP, Chief Business Officer		 2019-03-25 21:12:52 17,267
249,091		 266,358 Form 4
13 Nohria Virinder
Director		 2017-05-10 19:21:46 189,836
19,211		 209,047 Form 4/A
14 Kelly David George
EVP, Company Secretary		 2016-03-24 18:52:15 183,638
19,250		 202,888 Form 4
15 MOZE BARRY
EVP, Chief Admin. Officer		 2022-01-06 20:58:01 182,954
0		 182,954 Form 4
16 BIRD JEFFREY W
Director		 2014-03-13 16:35:57 0
178,406		 178,406 Form 4/A
17 Hoelscher Paul W.
EVP, CFO		 2022-04-22 18:47:19 37,473
139,462		 176,935 Form 4
18 DE VAERE ROBERT J
EVP & CFO		 2014-10-02 17:58:47 154,514
0		 154,514 Form 4
19 Kent Jeff
See remarks		 2021-05-12 17:02:34 126,994
0		 126,994 Form 4
20 Lin Shao-Lee
EVP, Head of R&D and CSO		 2020-01-23 16:22:44 121,930
0		 121,930 Form 4
21 Karnani Vikram
EVP & President, International		 2021-02-23 18:20:36 104,165
0		 104,165 Form 4
22 SMITH TODD N
EVP & Chief Commercial Officer		 2015-02-04 12:43:42 95,961
0		 95,961 Form 4/A
23 Konstantinovsky Irina
EVP, Chief Human Resources Off		 2021-02-23 18:19:57 81,677
0		 81,677 Form 4
24 Kody John J
EVP, Chief Commercial Officer		 2015-11-25 13:00:06 69,691
0		 69,691 Form 4
25 McHugh Miles W
Sr VP & Princ. Acctg Officer		 2022-01-06 21:02:57 67,044
0		 67,044 Form 4
26 ADATTO MICHAEL
SVP, Managed Care & Comm. Dev.		 2013-01-03 14:37:53 64,461
0		 64,461 Form 4
27 Beeler Brian K
EVP, General Counsel		 2021-09-17 17:06:11 62,775
0		 62,775 Form 4
28 Camardo Daniel A.
EVP and President, U.S.		 2021-04-05 17:25:18 58,955
0		 58,955 Form 4
29 CURTIS GEOFFREY M.
EVP, Corporate Affairs, CCO		 2021-04-02 17:13:34 52,675
420		 53,095 Form 4
30 HAMPTON GEORGE P
EVP, Primary Care Bus. Unit		 2018-04-02 16:24:07 48,473
0		 48,473 Form 4
31 LEONARDI JACOPO
Pres., Global Commercial Ops		 2022-06-03 18:07:38 44,466
0		 44,466 Form 4
32 ACKERMAN TIMOTHY J.
SVP, Commercial Operations		 2017-01-11 16:29:25 41,129
0		 41,129 Form 4
33 Thomas John B
EVP, Corporate Strategy and IR		 2016-05-10 16:43:50 35,745
0		 35,745 Form 4
34 Pauli Ronald
Director		 2019-05-06 17:44:38 0
33,600		 33,600 Form 4
35 Happel David
EVP, Commercial Dev & Strategy		 2017-10-26 19:39:36 28,949
0		 28,949 Form 4
36 Rosen Karin
EVP, R&D & CSO		 2021-01-06 21:15:14 24,449
0		 24,449 Form 4
37 Mosbrooker Eric
SVP, Orphan Business Unit		 2017-11-02 16:13:24 16,891
0		 16,891 Form 4
38 McIlvenny Patrick
Chief Accounting Officer		 2023-10-06 18:08:43 0
0		 0 Form 4
39 Watkins Thomas
Director		 2023-10-06 18:24:28 0
0		 0 Form 4
40 Mahony Susan
Director		 2023-10-06 18:22:58 0
0		 0 Form 4
41 Witz Pascale
Director		 2023-10-06 18:21:24 0
0		 0 Form 4
42 GREY MICHAEL G
Director		 2023-10-06 18:19:58 0
0		 0 Form 4
43 Daniel William F
Director		 2023-10-06 18:17:47 0
0		 0 Form 4
44 Himawan Jeff
Director		 2023-10-06 18:15:32 0
0		 0 Form 4
45 Shannon James Samuel
Director		 2023-10-06 18:13:09 0
0		 0 Form 4
46 SANTINI GINO
Director		 2023-10-06 18:10:03 0
0		 0 Form 4
47 Pasternak Andy
EVP, Chief Strategy Officer		 2023-10-06 18:03:58 0
0		 0 Form 4
48 Thompson Elizabeth H.Z.
EVP, Research & Development		 2023-10-06 18:01:21 0
0		 0 Form 4
49 Cox Aaron
EVP, Chief Financial Officer		 2023-10-06 17:59:28 0
0		 0 Form 4
50 Walbert Timothy P
Chairman, President and CEO		 2023-10-06 17:57:24 0
0		 0 Form 4
51 DesJardin Michael A.
EVP, Technical Operations		 2023-10-06 17:54:12 0
0		 0 Form 4
52 Clayton Sean M.
EVP, General Counsel		 2023-10-06 17:51:42 0
0		 0 Form 4
53 SHERMAN JEFFREY W
EVP and Chief Medical Officer		 2023-10-06 17:48:49 0
0		 0 Form 4
54 Vidara Therapeutics Holdings LLC
Former 10% Owner
10% Owner		 2014-09-23 17:04:00 0
0		 0 Form 13D